Go Pro

National Vision (EYE) Competitors

National Vision logo
$22.36 +0.31 (+1.43%)
As of 12:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EYE vs. NVST, STVN, BLCO, MMED, and LIVN

Should you buy National Vision stock or one of its competitors? MarketBeat compares National Vision with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with National Vision include Envista (NVST), Stevanato Group (STVN), Bausch + Lomb (BLCO), MiniMed Group (MMED), and LivaNova (LIVN).

How does National Vision compare to Envista?

National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are related companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

National Vision has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

In the previous week, Envista had 8 more articles in the media than National Vision. MarketBeat recorded 11 mentions for Envista and 3 mentions for National Vision. National Vision's average media sentiment score of 1.05 beat Envista's score of 1.03 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
7 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision currently has a consensus target price of $30.08, indicating a potential upside of 34.62%. Envista has a consensus target price of $28.62, indicating a potential upside of 4.18%. Given National Vision's stronger consensus rating and higher possible upside, equities analysts clearly believe National Vision is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38

Envista has higher revenue and earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.90$29.60M$0.5739.21
Envista$2.81B1.59$47M$0.4166.99

Envista has a net margin of 2.41% compared to National Vision's net margin of 2.31%. Envista's return on equity of 7.11% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
Envista 2.41%7.11%3.91%

Summary

Envista beats National Vision on 8 of the 13 factors compared between the two stocks.

How does National Vision compare to Stevanato Group?

National Vision (NASDAQ:EYE) and Stevanato Group (NYSE:STVN) are related companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

In the previous week, National Vision had 1 more articles in the media than Stevanato Group. MarketBeat recorded 3 mentions for National Vision and 2 mentions for Stevanato Group. National Vision's average media sentiment score of 1.05 beat Stevanato Group's score of 0.54 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stevanato Group has lower revenue, but higher earnings than National Vision. Stevanato Group is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.90$29.60M$0.5739.21
Stevanato Group€1.34B4.56€158.21M€0.5934.27

National Vision currently has a consensus price target of $30.08, suggesting a potential upside of 34.62%. Given National Vision's higher possible upside, research analysts plainly believe National Vision is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
3.00

Stevanato Group has a net margin of 11.76% compared to National Vision's net margin of 2.31%. Stevanato Group's return on equity of 10.27% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
Stevanato Group 11.76%10.27%6.08%

National Vision has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, Stevanato Group has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market.

Summary

Stevanato Group beats National Vision on 8 of the 15 factors compared between the two stocks.

How does National Vision compare to Bausch + Lomb?

National Vision (NASDAQ:EYE) and Bausch + Lomb (NYSE:BLCO) are related companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

In the previous week, Bausch + Lomb had 15 more articles in the media than National Vision. MarketBeat recorded 18 mentions for Bausch + Lomb and 3 mentions for National Vision. National Vision's average media sentiment score of 1.05 beat Bausch + Lomb's score of 0.31 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Bausch + Lomb
3 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

11.1% of Bausch + Lomb shares are owned by institutional investors. 2.4% of National Vision shares are owned by insiders. Comparatively, 1.5% of Bausch + Lomb shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

National Vision has a net margin of 2.31% compared to Bausch + Lomb's net margin of -3.21%. National Vision's return on equity of 6.41% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
Bausch + Lomb -3.21%4.14%1.93%

National Vision currently has a consensus target price of $30.08, suggesting a potential upside of 34.62%. Bausch + Lomb has a consensus target price of $18.75, suggesting a potential upside of 11.81%. Given National Vision's stronger consensus rating and higher possible upside, analysts clearly believe National Vision is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
Bausch + Lomb
1 Sell rating(s)
8 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.29

National Vision has higher earnings, but lower revenue than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.90$29.60M$0.5739.21
Bausch + Lomb$5.32B1.12-$360M-$0.48N/A

National Vision has a beta of 1.02, indicating that its stock price is 2% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

Summary

National Vision beats Bausch + Lomb on 12 of the 16 factors compared between the two stocks.

How does National Vision compare to MiniMed Group?

National Vision (NASDAQ:EYE) and MiniMed Group (NASDAQ:MMED) are related companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

In the previous week, MiniMed Group had 5 more articles in the media than National Vision. MarketBeat recorded 8 mentions for MiniMed Group and 3 mentions for National Vision. National Vision's average media sentiment score of 1.05 beat MiniMed Group's score of 0.20 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiniMed Group
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

National Vision has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.90$29.60M$0.5739.21
MiniMed Group$3.10B1.71-$190.97M-$0.68N/A

19.7% of MiniMed Group shares are owned by institutional investors. 2.4% of National Vision shares are owned by company insiders. Comparatively, 2.2% of MiniMed Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

National Vision currently has a consensus price target of $30.08, indicating a potential upside of 34.62%. MiniMed Group has a consensus price target of $21.62, indicating a potential upside of 14.16%. Given National Vision's higher possible upside, equities research analysts clearly believe National Vision is more favorable than MiniMed Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.75

National Vision has a net margin of 2.31% compared to MiniMed Group's net margin of 0.00%. National Vision's return on equity of 6.41% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
MiniMed Group N/A N/A N/A

Summary

National Vision beats MiniMed Group on 9 of the 15 factors compared between the two stocks.

How does National Vision compare to LivaNova?

National Vision (NASDAQ:EYE) and LivaNova (NASDAQ:LIVN) are related companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

97.6% of LivaNova shares are owned by institutional investors. 2.4% of National Vision shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, LivaNova had 6 more articles in the media than National Vision. MarketBeat recorded 9 mentions for LivaNova and 3 mentions for National Vision. LivaNova's average media sentiment score of 1.19 beat National Vision's score of 1.05 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
8 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

National Vision currently has a consensus target price of $30.08, indicating a potential upside of 34.62%. LivaNova has a consensus target price of $81.38, indicating a potential upside of 0.06%. Given National Vision's higher possible upside, equities research analysts clearly believe National Vision is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55
LivaNova
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

LivaNova has a net margin of 7.48% compared to National Vision's net margin of 2.31%. LivaNova's return on equity of 16.48% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision2.31% 6.41% 2.81%
LivaNova 7.48%16.48%7.59%

National Vision has higher revenue and earnings than LivaNova. National Vision is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.99B0.90$29.60M$0.5739.21
LivaNova$1.43B3.12-$242.47M$1.9541.71

National Vision has a beta of 1.02, meaning that its share price is 2% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Summary

LivaNova beats National Vision on 11 of the 16 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionSpecialty Retail IndustryConsumer Discretionary SectorNASDAQ Exchange
Market Cap$1.79B$11.41B$13.30B$12.66B
Dividend YieldN/A97.64%53.32%10.03%
P/E Ratio39.2030.8647.6125.05
Price / Sales0.9015.4390.7279.91
Price / Cash12.3113.3318.9346.71
Price / Book2.045.924.566.18
Net Income$29.60M$439.42M$444.15M$347.61M
7 Day Performance7.75%1.45%1.25%0.71%
1 Month Performance13.09%2.52%0.77%-3.75%
1 Year Performance-7.70%7.43%3.98%20.17%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
4.2103 of 5 stars
$22.35
+1.4%
$30.08
+34.6%
-9.0%$1.79B$1.99B39.2013,138
NVST
Envista
2.5842 of 5 stars
$27.06
+1.6%
$28.54
+5.4%
+31.8%$4.41B$2.81B66.0312,000
STVN
Stevanato Group
2.9498 of 5 stars
€20.16
+1.8%
N/A-20.9%€6.10B€1.34B34.166,010
BLCO
Bausch + Lomb
3.4174 of 5 stars
$16.42
+0.9%
$18.00
+9.6%
+24.9%$5.87B$5.21BN/A13,000
MMED
MiniMed Group
2.151 of 5 stars
$18.11
+2.5%
$21.62
+19.4%
N/A$5.10B$3.10BN/A8,000

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners